Zymergi LogoCart

483 Document: Havix Group Inc d/b/a Aavis Pharmaceuticals, Apr 19, 2022

FDANews 483 Havix Group Inc d/b/a Aavis Pharmaceuticals Apr 19 2022 top
Susan O. Oladeji FDA Investigator Gretchen M. Laws FDA Investigator

On Apr 19, 2022, the FDA inspected Havix Group Inc d/b/a Aavis Pharmaceuticals's Hoschton site. Explore the inspectional observations.